Information on all patients treated at our institution is recorded on a database. This information is used to monitor the results of treatment in our unit. From time to time we present data from this information to other specialists in the form of lectures or publications. Naturally all these presentations do not disclose any identifying details of our patients.
During the course of treatment you may be approached by one of our scientists who will ask your permission to collect tissue sample from your tumour on which to perform research.
Please do not hesitate to ask your surgeon or Cancer Nurse Coordinator for information regarding research.
Cancer Surgery Research Foundation (CanSur)
CanSur was established in 1999 as a not-for profit charity. This has been an active foundation supporting the research in our unit. The inaugural board members included Professor Ross Smith, John Burgess and Dr Tom Hugh.
The work of CanSur has been recognised by the NSW State government who generously supported th establishment of a network of surgeons to work together on the treatment of pancreatic cancer. This required the purchase of several -70 C refrigeration units in a number of hospitals, and the establishment of an internet facility to allow communication between these units.
The Bill Walsh Cancer research
The Kolling Institute of Medical ResearchThe Bill Walsh Translational Cancer Research Laboratory is the research arm of the Medical Oncology Department at Royal North Shore Hospital. It is part of the Hormones and Cancer Division of the Kolling Institute of Medical Research which is affiliated with Sydney Medical School at the University of Sydney and is a member of the Cancer Institute NSW Northern Translational Cancer Research Unit.
We are located in the Kolling Building at Royal North Shore Hospital.
We focus on increasing understanding of cancer biology, identifying better ways to diagnose and predict how a cancer will behave, and improving cancer treatment for better outcomes for cancer patients.
Our team of medical oncologists and cancer researchers work together to fast-track discoveries into clinical practice.
The close link between our laboratory and the clinic is represented in our logo of two cancer ribbons intersecting; one ribbon representing the laboratory, and the other representing the clinic.
In 2013 we renamed the laboratory by the addition of “Translational”. This signifies our mission to “translate” or convert critical findings from the laboratory to the clinic, with the goal of improving cancer treatments and curing or stopping the spread of the malignancy in those cancers for which there remains a grim prognosis.
Publications
Factors associated with postoperative pulmonary morbidity after esophagectomy for cancer. U Zingg, DC Gotley, BM Smithers, G Smith, A Aly, A Clough, AJ Esterman, GG Jamieson, DI Watson. Accepted. Annals of Surgical Oncology
Symptoms, investigations and management of patients with cancer of the oesophagus and gastro-oesophageal junction in Australia BM Smithers, PP Fahey, T Corish, DCGotley, GL Falk, GS Smith, GK Kiroff, AD Clouston, DI Watson, DC Whiteman. MJA 2010; 193 (10): 572-577
Mortality and survival associated with oesophagectomy in New South Wales; an investigation of hospital volume and peer-group. Stavrou EP, Smith G, Baker DF.
J Gastrointest Surg.2010 Jun; 14(6):951-7
Prosthesis related sepsis after laparoscopic adjustable gastric banding. Facek M, Reseeveur I, Darbar A, Richardson A, Leibman S, Smith GS. In Press Aust NZJ Surg
Omission of calibration bougie for the laparoscopic repair of paraoesophageal hernia. Ng A, Yong D, Hazebroek EJ, Berry H, Leibman S, Smith GS. Surg Endosc. 2009 Nov;23(11):2505-8.
Adenocarcinoma of the oesophagus: incidence and survival rates in New South Wales, 1972-2005. Stavrou EP, McElroy HJ, Baker DF, Smith G, Bishop JF. Med J Aust. 2009 Sep 21;191(6):310-4.
Cartilage defects are associated with physical disability in obese adults. Anandacoomarasamy A, Smith G, Leibman S, Caterson I, Giuffre B, Fransen M,Sambrook P, March L. Rheumatology 2009 Oct;48(10):1290-3.
Influence of BMI on health-related quality of life comparison between an obese adult cohort and age-matched population norms. Anandacoomarasamy A, Caterson I, Leibman S, Smith G, Sambrook P, Fransen M, March L Obesity 2009 Nov;17(11):21114-8.
Delayed Gadolinium-Enhanced Magnetic Resonance Imaging of Cartilage: Clinical associations in obese adults.
Anandacoomarasamy A, Caterson I, Smith G, Leibman S, Chen JS, Giuffre B, Fransen M, Sambrook P, March L. J Rheumatol. 2009 May;36(5):1056-62.
Heller myotomy – Is a fundoplication really necessary?
Smith GS.
Aust NZJ Surg 2008:78(10);839
Evaluation of laparoscopic repair of large hiatal hernias with TiMesh: symptomatic relief, patient satisfaction and quality of life.
EJ Hazebroek, A Ng, DHK. Yong, H Berry, S Leibman, GS Smith.
Aust NZ J Surg 2008:78(10);914-917
Short term symptom and quality of life comparison between laparoscopic Nissen and Toupet fundoplications.
Radajewski R, Hazebroek EJ, Berry H, Leibman S, Smith GS
Dis Esophagus. 2009;22(1):84-8.
Laparoscopic ePTFE mesh repair of inscisional and ventral hernias.
S Gananadha, J Samra, GS Smith, RC Smith, S Leibman, TJ Hugh
Aust NZJ Surg 2008:78(10);907-913
Evaluation of lightweight titanium-coated polypropylene mesh (TiMesh) for laparoscopic repair of large hiatal hernias.
EJ Hazebroek, H Berry, S Leibman, GS Smith
Surg Endosc. 2008 Nov;22(11):2428-32.
Total oesophagogastric dissociation in adult neurologically impaired patients with severe gastro-oesophageal reflux: an alternative approach.
Hazebroek HJ, Leibman S, Smith GS
Dis Esophagus. 2008;21(8):742-5.
Critical evaluation of a novel DualMesh repair for large hiatal hernias.
EJ Hazebroek, Y Koak, H Berry, S Leibman, GS Smith
Surg Endosc. 2009 Jan;23(1):193-6.
Laparoscopic para-oesophageal hernia repair – quality of life outcomes in the elderly
EJ Hazebroek, S Gananahda, Y Koak, H Berry, S Leibman, GS Smith
Dis Esophagus. 2008;21(8):737-41.
The utility of FDG-PET in the pre-operative staging of oesophageal cancer.
S Gananadha, EJ Hazebroek, S Leibman, H Berry, L Osgood, I Ho Shon, N Pavlakis, G Marx, GS Smith
Dis Esophagus. 2008;21(5):389-94.
Evaluation of DualMesh for repair of large hiatus hernia in a porcine model.
Smith GS, Hazebroek EJ, Eckstein R, Berry H, Smith WM, Isaacson JR, Falk GL, Martin CJ.
Surg Endosc. 2008 Jul;22(7):1625-31.
The case for mesh repair in hiatal surgery
GS Smith
Ann R Coll Surg Engl. Jul 2007 Ann R Coll Surg Engl. 2007 Jul;89(5):481-3.
Pulmonary manifestations of gastro-oesophageal reflux disease
Joffe D, Smith GS, Stiel D
Australian Doctor Oct 2004, 27-34
Symptomatic and radiological follow up after para-oesophageal hernia repair.
Smith GS, Isaacson JR, Draganic BD, Baladas HG, Falk GL
Dis Esophagus 2004;17(4): 279-84
Laparoscopic management of large paraesophageal hiatal hernia
Leeder PC, Smith GS, Dehn TC,
Surg.Endosc.2003 Sept; 17(9):1372-5. Epub 2003 June 25.
Cancer Surgery Research Foundation (CanSur)
CanSur was established in 1999 as a not-for profit charity. This has been an active foundation supporting the research in our unit. The inaugural board members included Professor Ross Smith, John Burgess and Dr Tom Hugh.
The work of CanSur has been recognised by the NSW State government who generously supported th establishment of a network of surgeons to work together on the treatment of pancreatic cancer. This required the purchase of several -70 C refrigeration units in a number of hospitals, and the establishment of an internet facility to allow communication between these units.
The Bill Walsh Cancer research
The Kolling Institute of Medical ResearchThe Bill Walsh Translational Cancer Research Laboratory is the research arm of the Medical Oncology Department at Royal North Shore Hospital. It is part of the Hormones and Cancer Division of the Kolling Institute of Medical Research which is affiliated with Sydney Medical School at the University of Sydney and is a member of the Cancer Institute NSW Northern Translational Cancer Research Unit.
We are located in the Kolling Building at Royal North Shore Hospital.
We focus on increasing understanding of cancer biology, identifying better ways to diagnose and predict how a cancer will behave, and improving cancer treatment for better outcomes for cancer patients.
Our team of medical oncologists and cancer researchers work together to fast-track discoveries into clinical practice.
The close link between our laboratory and the clinic is represented in our logo of two cancer ribbons intersecting; one ribbon representing the laboratory, and the other representing the clinic.
In 2013 we renamed the laboratory by the addition of “Translational”. This signifies our mission to “translate” or convert critical findings from the laboratory to the clinic, with the goal of improving cancer treatments and curing or stopping the spread of the malignancy in those cancers for which there remains a grim prognosis.
